ISSCR: grave omission of age limit for embryo research
By Josephine Johnston, Françoise Baylis, & Henry T. Greely,
Nature
| 06. 22. 2021
We are researchers with differing views on the ethics of stem-cell and embryo research who nonetheless share deep concerns about the latest guidelines from the International Society for Stem Cell Research (ISSCR; see R. Lovell-Badge Nature 593, 479; 2021).
The 2016 ISSCR guidelines ruled out experiments on human embryos beyond 14 days, citing broad international consensus that these lacked “a compelling scientific rationale, raise substantial ethical concerns, and/or are illegal in many jurisdictions” (see go.nature.com/3cqc4bw). The latest guidelines drop this prohibition (see go.nature.com/3gfkkw8) and do not propose any alternative.
At some point, the developing human embryo reaches a stage at which it should not be used for research. There is disagreement about when that happens, but scientists need to acknowledge that it does, and reassure the public that they accept limits. The latest guidelines do not prohibit the development or research use of ex vivo embryos at any stage.
Defining and defending a new limit, and possible constraints within it, will be hard. This was the case for the 14-day cut-off, selected some 40 years...
Related Articles
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...
By Christina Jewett, The New York Times | 06.05.2025
Health Secretary Robert F. Kennedy Jr. recently declared that he wanted to expand access to experimental therapies but conceded that they could be risky or fraudulent.
In a podcast with Gary Brecka, who describes himself as a longevity expert...
By Mike Baker, The New York Times | 02.25.2025
As investigators struggled for weeks to find who might have committed the brutal stabbings of four University of Idaho students in the fall of 2022, they were focused on a key piece of evidence: DNA on a knife sheath that...
By David Jensen, Capitol Weekly | 02.19.2025
California scientists took what looked like an $800 million hit last week in their efforts to develop revolutionary treatments and cures for diseases ranging from cancer to diabetes.
It was a jab from the Trump administration, one that generated apocalyptic...